Monday, December 01, 2025




In Detail Full day, Monday, December 01, 2025, Timezone: America/Chicago


UK and US agree zero-tariff deal on pharmaceuticals / ABC News

go - Officials say the U.K. has sealed a deal securing a 0% tariff rate for all U.K. medicines exported to the U.S. for at least 3 years, in return for the U.K. spending more on new medicines

#healthcare #pharmaceuticals #drugpricing #governmentpolicy


Monday, December 1, 2025, 1:23 pm / permalink 16444 / 6 stories in 3 months


FDA approves all ages gene therapy for spinal condition / Beckers

Ella Jeffries / beckershospitalreview - The FDA approved Novartis’ Itvisma (onasemnogene abeparvovec-brve), the company’s first and only gene replacement therapy for spinal muscular atrophy in children 2 and older, as well as for teens and adults. The therapy is designed to address the genetic …

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda


Monday, December 1, 2025, 4:21 am / permalink 16428 / 2 stories in 3 months


StackHealth Time Machine




Outgoing Stories


HIMSS 2026 pushes real‑time data, cloud and interoperability playbook 14 stories in 18.5 hours

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma 3 stories in 19.5 hours

Vitamin D trial shows reduced long‑COVID risk but no severity benefit 2 stories in 21.5 hours

Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival 4 stories in 22.4 hours

FDA approves leucovorin for rare folate disorder despite autism hype 4 stories in 34.5 hours

HORMAD1 emerges as a potential target in triple‑negative breast cancer 4 stories in 47.5 hours

Alfasigma pays $300M to GSK for linerixibat rights, expanding liver-disease portfolio 2 stories in 50.5 hours

Roche’s hoped‑for breast cancer pill fails crucial first‑line trial 5 stories in 51.5 hours

Novo Nordisk and Hims bury the hatchet and carve a deal 3 stories in 56.5 hours

AI improves UK breast-screening detection by about 10% 5 stories in 56.5 hours


More StackHealth


Bluesky:



NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.